Exicure completes the last patient, last visit in phase 2 study of gpc-100 for stem cell mobilization in multiple myeloma patients undergoing autologous transplant

Redwood city, calif.--(business wire)--exicure completes the last patient, last visit in phase 2 study of gpc-100 for stem cell mobilization in multiple myeloma patients.
XCUR Ratings Summary
XCUR Quant Ranking